India's Serum Institute withholds AstraZeneca doses to contend with extensive increase in domestic cases
Article content
A horrific third wave in India is delaying an expected shipment of 1.5 million doses of AstraZeneca vaccines that had been set to arrive in Canada this month.
India’s Serum Institute signed a contract with Canada earlier this year to provide two million doses of their version of the AstraZeneca vaccine to Canada. The first 500,000 doses arrived in March, with a further shipment of a million doses expected in April, and the remainder of the order expected in mid-May.
Public Services and Procurement Canada’s director general Joëlle Paquette said those shipments are delayed, but the company still says it expects to eventually fulfill its order.
“The company is committed to supply their 1.5 million doses, and we’re still tracking that for the end of June. Obviously the situation in India and the exportation ban may affect that particular delivery,” she said.
India is in the midst of a rapidly accelerating third wave and had more than 300,000 new cases on Wednesday alone. Hospitals in the country are struggling to keep up with demand for oxygen for critically ill patients.
The country of 1.3 billion people was averaging around 40,000 cases a day just a month ago, but the virus had surged over the last month and the government has stopped all vaccine exports for the time being.
Advertisement
Story continues below
This advertisement has not loaded yet, but your article continues below.
Article content
Canada has received a total of 2.3 million doses of the AstraZeneca vaccine so far: the initial shipment from India was followed later in March by a shipment from the United States of 1.5 million doses and a shipment last week of just over 300,000 doses through the COVAX facility.
The COVAX facility pools money from developed countries and uses it to buy vaccines for those countries and for the developing world. Canada should receive more doses from COVAX, but there is no date on when.
The 1.5 million doses from the U.S. were part of an order of 20 million the Trudeau government purchased, but President Joe Biden’s administration is preventing exports from the U.S. until America has an adequate supply.
Biden allowed for the 1.5 million doses to be shipped in March and said Thursday he was hoping to have more shipments to Canada soon, but there is no clear timeline on those deliveries. The American Food and Drug administration has yet to approve AstraZeneca’s vaccine and doses produced there are currently going unused.
Canada saw a surge of AstraZeneca doses used this week after several provinces opened up their use to people as young as 40. Due to an extremely rare risk of blood clots, provincial health officials had paused use of the AstraZeneca vaccine in people under 55 earlier this month.
Advertisement
Story continues below
This advertisement has not loaded yet, but your article continues below.
Article content
Canada saw a surge of AstraZeneca doses used this week after several provinces opened up their use to people as young as 40. Due to that risk, provincial health officials paused use of the AstraZeneca vaccine in people under 55 earlier this month after a recommendation from the National Advisory Council on Immunization.
After a review by Health Canada and the National Advisory Committee on Immunization (NACI), some provinces dropped the age to 40 on Tuesday. Dr. Howard Njoo, Canada’s deputy chief public health officer, said the clots are still exceedingly rare.
“There have been a few reported cases of a very rare event, following administration of over 1.1 million doses of the AstraZeneca vaccine.”
NACI had a press conference scheduled earlier this week to update its stance on AstraZeneca, but cancelled it at the last minute to review more data.
Canada is next week set to receive another million Pfizer doses and 300,000 doses of Johnson and Johnson’s one-shot vaccine. Moderna is expected to ship 650,000 doses next week, about half of what was initially expected as the company deals with manufacturing issues.
Advertisement
Story continues below
This advertisement has not loaded yet, but your article continues below.
Article content
Maj.-Gen. Dany Fortin, the Public Health Agency of Canada’s vice-president of logistics and operations, said despite the setbacks with Moderna and AstraZeneca, he expects the vaccine deliveries will only trend up, with Pfizer set to double its weekly deliveries beginning in May. He said he was also optimistic Moderna would clear its challenges.
“I think we’ll have very positive news in short order with Moderna,” he said. “The total amount of vaccine doses this quarter alone is well above 40 million and we will feel that significant increase starting the week after next.”
The AstraZeneca vaccine is a two-dose vaccine and despite the delays, Fortin said he is confident the second doses will be available when Canadians need them.
“At this point, I don’t think that we should worry about availability of second doses. What we’re focusing on is scaling up.”
Twitter: RyanTumilty | Email: rtumilty@postmedia.com
Advertisement
Story continues below
This advertisement has not loaded yet, but your article continues below.
India suspends vaccine exports as cases skyrocket, stalling Canadian deliveries - National Post
Read More
Tidak ada komentar:
Posting Komentar